丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
niciane 50 mikrogram/dosis næsespray, suspension
viatris limited - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxae 50 mikrogram/dosis næsespray, suspension
laboratoires gerda - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
parilo 50 mikrogram/dosis næsespray, suspension
laboratoires gerda - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
prausin 50 mikrogram/dosis næsespray, suspension
eg labo - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
ryaltris 25+600 mikrog./dosis næsespray, suspension
paranova danmark a/s - mometasonfuroat monohydrat, olopatadinhydrochlorid - næsespray, suspension - 25+600 mikrog./dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
asmanex twisthaler 400 mikrogram/dosis inhalationspulver
n.v. organon - mometasonfuroat - inhalationspulver - 400 mikrogram/dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
asmanex twisthaler 400 mikrogram/dosis inhalationspulver
orifarm a/s - mometasonfuroat - inhalationspulver - 400 mikrogram/dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
ledercort "rx" 50 mikrogram/dosis næsespray, suspension
dymalife pharmaceutical srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
丹麦 -
丹麦文 -
Lægemiddelstyrelsen (Danish Medicines Agency)
metacort 50 mikrogram/dosis næsespray, suspension
s.f. group s.r.l. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
欧盟 -
丹麦文 -
EMA (European Medicines Agency)
tybost
gilead sciences ireland uc - cobicistat - hiv infektioner - antivirale midler til systemisk anvendelse - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.